Daewoong Pharmaceutical hosts global academy for NABOTA partners

Daewoong Pharmaceutical held the ‘NABOTA EDGE: Global Academic Program’ in Jeju from the 3rd to the 5th to strengthen the academic and marketing capabilities of its international partners. The event hosted 40 key personnel from partner companies representing 22 countries.

NABOTA, the company’s flagship botulinum toxin product, has surpassed 1 trillion won in cumulative sales and is projected to reach 300 billion won in annual sales this year. The product currently holds marketing authorization in 69 countries across the US, Europe, and Asia, with partnerships established in approximately 80 countries.

The program focused on enhancing the practical competitiveness of partner sales and academic staff through customized training. Topics included market entry strategies, basic anatomy, standard procedure guides, and post-treatment care. Participants also shared local market success stories and benchmarked various regional execution know-hows to ensure consistent brand messaging globally.